APA (7th ed.) Citation

Iltar, U., Atas, U., Yucel, O. K., Salim, O., & Ündar, L. (2026). JC Virus Reactivation Should Be Considered in Late Neurotoxicity Associated with Bispecific Antibody Therapy: A Comment. Comment on Bangolo et al. Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies. Cancers 2025, 17 , 282. Cancers, 18(10), 1506. https://doi.org/10.3390/cancers18101506

Chicago Style (17th ed.) Citation

Iltar, Utku, Unal Atas, Orhan Kemal Yucel, Ozan Salim, and Levent Ündar. "JC Virus Reactivation Should Be Considered in Late Neurotoxicity Associated with Bispecific Antibody Therapy: A Comment. Comment on Bangolo Et Al. Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies. Cancers 2025, 17 , 282." Cancers 18, no. 10 (2026): 1506. https://doi.org/10.3390/cancers18101506.

MLA (9th ed.) Citation

Iltar, Utku, et al. "JC Virus Reactivation Should Be Considered in Late Neurotoxicity Associated with Bispecific Antibody Therapy: A Comment. Comment on Bangolo Et Al. Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies. Cancers 2025, 17 , 282." Cancers, vol. 18, no. 10, 2026, p. 1506, https://doi.org/10.3390/cancers18101506.